Infections of the female genital tract

Primary Care - Clinics in Office Practice

Volumn 30, Issue 1, 2003, Pages 193-203

  Nasraty, Soraya ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIFUNGAL AGENT; AZITHROMYCIN; BUTOCONAZOLE; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; ECONAZOLE; ERYTHROMYCIN; FLUCONAZOLE; GATIFLOXACIN; IMIQUIMOD; KETOCONAZOLE; LOMEFLOXACIN; METRONIDAZOLE; MICONAZOLE; NORFLOXACIN; OFLOXACIN; PODOPHYLLOTOXIN; PROBENECID; SPECTINOMYCIN; TERCONAZOLE; TIOCONAZOLE; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; CANDIDIASIS; FEMALE; FEMALE GENITAL TRACT INFECTION; GONORRHEA; HERPES SIMPLEX VIRUS; HUMAN; NAUSEA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; TASTE AVERSION; TASTE DISORDER; TRICHOMONIASIS; VAGINITIS; WART VIRUS;

EID: 0037358874     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(02)00055-6     Document Type: Review

References (15)

1. Sobel JD. Vaginitis. New Engl J Med 1997;337:1896-903.
2. Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J, BV Study Group. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 2001;91:1664-70.
3. Priestley CJ, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med 1997;73:23-8.
4. Rein MF. Vulvovaginitis and cervicitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th edition. Vol. 1. Philadelphia: Churchill Livingstone; 2000. p. 1218-35.
5. Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines 2002. MMWR 2002;51(RR-6):12-57.
6. Kane KY, Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract 2001;50:399-400.
7. Lurie S, Woliovitch I, Glezerman M. Short anovaginal distance: a risk factor for recurrent vaginitis. Int J Gynecol Obstet 2000;71:279-80.
8. Rein MF. Trichomonas vaginalis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th edition. Vol. 1. Philadelphia: Churchill Livingstone; 2000. p. 2894-98.
9. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997;176(1 Pt 1):103-7.
10. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001; 20(3 Suppl):95-107.
11. Jones RB, Batteiger BE. Chlamydia trachomatis (trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infections diseases. 5th edition. Vol. 1. Philadelphia: Churchill Livingstone; 2000. p. 1990-2002.
12. US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med 2001;20(3 Suppl):90-4.
13. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998;178:1272-8.
14. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 1998;178:987-90.
15. Eschenbach DA, Wolner-Hanssen P, Hawes SE, Pavletic A, Paavonen J, Holmes KK. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Obstet Gynecol 1997;89:184-92.